Prognostic value of neutrophil-to-lymphocyte ratio in localized and advanced prostate cancer: a systematic review and meta-analysis
L Tang, X Li, B Wang, G Luo, L Gu, L Chen, K Liu… - PloS one, 2016 - journals.plos.org
Objective and Background Increasing evidence suggests that inflammation plays an
essential role in cancer development and progression. The inflammation marker neutrophil …
essential role in cancer development and progression. The inflammation marker neutrophil …
Predictive factors for gleason score upgrading in patients with prostate cancer after radical prostatectomy: a systematic review and meta-analysis
Y Wang, X Chen, K Liu, R Liu, L Li, C Yin… - Urologia …, 2023 - karger.com
Introduction: Previous studies have revealed that Gleason score upgrading (GSU) was
closely related to an increased biochemical recurrence rate and adverse oncologic …
closely related to an increased biochemical recurrence rate and adverse oncologic …
The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A …
S Wang, Y Ji, Y Chen, P Du, Y Cao, X Yang… - Frontiers in …, 2022 - frontiersin.org
Purpose To evaluate the diagnostic values of systemic immune-inflammation index (SII) and
neutrophil–lymphocyte ratio (NLR) in patients with localized prostate cancer (PCa). Methods …
neutrophil–lymphocyte ratio (NLR) in patients with localized prostate cancer (PCa). Methods …
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients
M Ferro, G Musi, A Serino, G Cozzi, FA Mistretta… - Urologia …, 2019 - karger.com
Background: Several biochemical and clinical markers have been proposed for selecting
patients for active surveillance (AS). However, some of these are expensive and not easily …
patients for active surveillance (AS). However, some of these are expensive and not easily …
[PDF][PDF] The neutrophil-to-lymphocyte ratio in clinical practice
A Gürağaç, Z Demirer - Canadian Urological Association Journal, 2016 - cuaj.ca
We read with great interest the article,“Evaluation of neutrophil-to-lymphocyte ratio prior to
prostate biopsy to predict biopsy histology: Results of 1836 patients,” by Gokce et al. 1 …
prostate biopsy to predict biopsy histology: Results of 1836 patients,” by Gokce et al. 1 …
Diagnostic efficiency of systemic immune-inflammation index in fusion prostate biopsy
Objective To investigate the diagnostic efficiency of systemic immune response (SII) in
prostate cancer (PCa) in patients with PSA< 10 ng/mL undergoing fusion prostate biopsy …
prostate cancer (PCa) in patients with PSA< 10 ng/mL undergoing fusion prostate biopsy …
Screening of differentially expressed genes and identification of AMACR as a prognostic marker in prostate cancer
P Fu, C Bu, B Cui, N Li, J Wu - Andrologia, 2021 - Wiley Online Library
Prostate cancer, the second most common cancer found in male over the world, was
estimated to have 191,930 new cases and 33,330 deaths in 2020 in the United States …
estimated to have 191,930 new cases and 33,330 deaths in 2020 in the United States …
Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl
V Caglayan, E Onen, S Avci… - Archivio Italiano di …, 2018 - pagepressjournals.org
Objective: To evaluate the diagnostic value of serum inflammation markers derived from
complete blood count in diagnosis of prostate cancer (PCa). Methods: We retrospectively …
complete blood count in diagnosis of prostate cancer (PCa). Methods: We retrospectively …
Assessment of PSIM (prostatic systemic inflammatory markers) score in predicting pathologic features at robotic radical prostatectomy in patients with low-risk prostate …
M Ferro, G Musi, DV Matei, AF Mistretta, S Luzzago… - Diagnostics, 2021 - mdpi.com
Background: circulating levels of lymphocytes, platelets and neutrophils have been
identified as factors related to unfavorable clinical outcome for many solid tumors. The aim of …
identified as factors related to unfavorable clinical outcome for many solid tumors. The aim of …
[HTML][HTML] Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active …
MI Gokce, S Tangal, N Hamidi, E Suer… - Canadian Urological …, 2016 - ncbi.nlm.nih.gov
Methods We retrospectively evaluated data of 210 low-risk PCa patients eligible for AS, but
who underwent radical prostatectomy. The roles of NC, LC, and NLR on the GS upgrading …
who underwent radical prostatectomy. The roles of NC, LC, and NLR on the GS upgrading …